Stephen Jameson, Ph.D., and David Masopust, Ph.D., published a paper online in the journal Nature, demonstrating a new way to study mice that better mimics the immune system of adult humans, which could significantly improve potential therapeutics.
Masonic Cancer Center researchers find DNA imprinting defects in children with osteosarcoma
Research spearheaded by Masonic Cancer Center researcher Subbaya Subramanian, Ph.D., associate professor in the U of M's Department of Surgery, found that DNA imprinting defects are associated with the development and progression of osteosarcoma. The study is published in the journal Oncotarget.
University of Minnesota researcher receives $432,000 grant to fight cancer in dogs
Jaime Modiano, V.M.D., Ph.D., professor in the College of Veterinary Medicine and the Masonic Cancer Center, University of Minnesota, will be leading a team of researchers in an exciting new study to better understand and prevent hemangiosarcoma, an aggressive form of cancer in dogs.
Masonic Cancer Center researcher discovers resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3B
Reuben Harris, Ph.D., Genetic Mechanisms of Cancer Program, presented his discovery that resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3B at the San Antonio Breast Cancer Symposium.
Masonic Cancer Center to offer new summer undergraduate research program
A new summer research program at the Masonic Cancer Center will open applications to undergraduate students at the University of Minnesota in November in an effort to inspire more students to consider training and careers in cancer research.
Masonic Cancer Center awarded NIH grant to focus on the environment and pediatric disease
Researchers at the Masonic Cancer Center, University of Minnesota have been awarded $5.1 million over four years to provide access to infrastructure for analysis and expanding collaboration on tools to study environmental impacts on children's health.
Killebrew-Thompson Memorial Golf Tournament provides decades of support for Masonic Cancer Center research
Every August for the past 38 years, the Killebrew-Thompson Memorial Golf Tournament in Sun Valley, Idaho has gathered celebrities, sponsors, participants, members of Congress and supporters with one common goal: to find a cure for cancer and leukemia. Founded in 1976 by Harmon Killebrew and Ralph Harding in memory of the Minnesota Twins’ shortstop, Danny Thompson, the Tournament is now considered one of the leading fundraisers of its kind for cancer research.
Proceeds from the event benefit the St. Luke’s Mountain States Tumor Institute in Boise and the Masonic Cancer Center, University of Minnesota. Due to the dedicated commitment of our supporters over the years, the Tournament has raised in excess of $13.8 million which has gone directly to cancer and leukemia research.